Why Telik (TELK) Stock Is Soaring Today

NEW YORK (TheStreet) -- Telik  (TELK) soared Tuesday after Monday's announcement that the oncology drug development company had entered into a definitive merger agreement with privately held MabVax Therapeutics

The two companies will combine into a publicly-traded company via an all-stock transaction. The new company will focus on "the development of proprietary immunotherapy-based products to diagnose and treat cancer," according to a press release.

The new company will be known as MabVax Therapeutics Holdings and the MabVax management team will lead it. J. David Hansen, President and CEO of MabVax, will serve as President, CEO, and Chairman of the Board of the new company. Michael M. Wick, M.D., Ph.D., who currently serves as President and CEO of Telik, will remain on the board.

Must Read: Telik, Biotech Pariah, Finally Died

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

The stock was up 27.28% to $1.59 at noon.

For more on Telik, read TheStreet's Adam Feuerstein's article here.

TELK Chart

TELK data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

More from Markets

Trump's Trade War May Test Investors More Than China's Economy

Trump's Trade War May Test Investors More Than China's Economy

Dow, S&P 500 Set Record Highs as Wall Street Looks Past Trade Fears

Dow, S&P 500 Set Record Highs as Wall Street Looks Past Trade Fears

'Blockchain Is to Bitcoin as Internet Is to Dot Com Bubble,' Says Zillow CEO

'Blockchain Is to Bitcoin as Internet Is to Dot Com Bubble,' Says Zillow CEO

Former GE Exec Beth Comstock Reveals This Dire Change Companies Need to Make

Former GE Exec Beth Comstock Reveals This Dire Change Companies Need to Make

Will Aston Martin IPO Result in 163% Gains Like Ferrari?

Will Aston Martin IPO Result in 163% Gains Like Ferrari?